{
    "code": 0,
    "data": [
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "We would like to inform you that the Board of Directors has in its meeting held today i.e. 11.02.2026 inter-alia considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31.12.2025. The same was also reviewed by the Audit Committee in its meeting held today. A copy of the said financial results along with Limited Review Report is enclosed herewith.",
            "news_id": "7d38381d-f9ff-4a6d-b096-cbb1a94621b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca9ac6e-5776-4f30-81c2-d3ab97427844.pdf",
            "news_date": "2026-02-11 19:57:30",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025. The same were also reviewed by the Audit Committee in its meeting held on November  14 2025.",
            "news_id": "f1df31f3-8398-4cc7-ab76-eb0890c67e70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168e22ef-d456-40bd-99ff-dc4ce5d7ddcc.pdf",
            "news_date": "2025-11-14 17:24:44",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2025",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results for quarter ended June 30 2025. A copy of the said results along with Limited Review Report is attached herewith",
            "news_id": "078ba840-9a52-4d76-b9bb-0416668915e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae14fd81-cc46-4e60-903b-65a3c8bd21f2.pdf",
            "news_date": "2025-08-14 18:25:08",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Along With Auditors Report For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "The Standalone and Consolidated financial results for quarter and financial year ended March 31 2025 is attached herewith.",
            "news_id": "fdb3b753-36d9-4fee-903d-45a51a60d8f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9c2b03f-7688-4c0e-8880-188d6b327f8c.pdf",
            "news_date": "2025-05-30 20:22:16",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "The Board of Directors in its meeting held today i.e. 14.02.2025 inter-alia considered and approved the unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2024.\r\n\r\nThe said results are enclosed herewith as annexure.",
            "news_id": "3e3e818c-5f12-4446-86be-b8e33e6b82b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6930f3c-9142-4881-8bfb-97a1ef113ac7.pdf",
            "news_date": "2025-02-14 18:42:40",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results (Provisional) for quarter and half year ended September 30, 2024",
            "news_id": "837d5164-fe8a-4a53-b144-416b8186a8a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=673fc0ef-0ffd-4bb8-94c3-10df0ee870e3.pdf",
            "news_date": "2024-11-13 15:51:30",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2024",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2024 along with Limited Review Report",
            "news_id": "d7305297-860b-4795-9a6b-1d97274eaba4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=103231a5-6a34-4ed3-9ba5-aa26766593e5.pdf",
            "news_date": "2024-08-14 16:25:20",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "The Board of Directors in its meeting held on May 30, 2024 approved the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024",
            "news_id": "b475646d-1855-4dac-bb76-b1c69e9bfc95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64585325-909c-468f-b4f3-8f447ed63d93.pdf",
            "news_date": "2024-05-30 14:22:40",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited financial results for quarter and nine months ended December 31, 2023 are enclosed herewith as Annexure -A",
            "news_id": "e54875ed-a6bd-4503-9095-11cebc15a74b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d676c4-86be-4322-8347-8b6716280bad.pdf",
            "news_date": "2024-02-13 14:50:02",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Please find enclosed herewith the Unaudited Standalone and Consolidated Financial results (Provisional) of the Company for quarter and half year ended September 30, 2023, as approved by the Board of Directors in its meeting held today i.e. November 10, 2023",
            "news_id": "e04884b8-648b-4e7d-bc2e-51c4f01de349",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=524de7f4-25f9-4886-b960-51e4320816b8.pdf",
            "news_date": "2023-11-10 13:44:48",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results (Provisional) Of The Company For The Quarter Ended June 30, 2023",
            "news_body": "The Board of Directors in its meeting held on August 12, 2023, has considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023.<BR> <BR> The meeting of the Board commenced at 11:30 A.M. and concluded at 3:00 P.M.",
            "news_id": "686d8690-6ffc-4af0-b99a-207c4d364ae7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29959a98-0be7-43a9-96f3-6e917fa8ef0c.pdf",
            "news_date": "2023-08-12 15:17:47",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023",
            "news_body": "The Board of Directors of the Company has, at its meeting held today, i.e. May 30, 2023, inter-alia, considered and approved the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. The same were also reviewed by the Audit Committee in its meeting held on May 29, 2023.A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A.The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 2:30 P.M.",
            "news_id": "00dd74a7-4c60-48a1-b394-d99a93ed2b10",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1aaf66d-aadc-4b62-a41e-7c0ea3a8eb6a.pdf",
            "news_date": "2023-05-30 14:53:02",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In continuation to our letter dated February 14, 2023, we would like to inform you that we have noted that due to inadvertent typographical/clerical error, the consolidated figures for Depreciation and amortisation expenses and Finance costs for the nine months ended December 31, 2022 as mentioned in the Statement of Standalone and Consolidated Financial Results (Unaudited) for the quarter and nine months ended December 31, 2022 were replaced with each other as a result of which the consolidated figures for these items for the quarter and nine months ended December 31, 2022 got mentioned incorrect.",
            "news_id": "f0f73065-e112-4abc-be38-4f5644dc210b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae927907-d42f-49ed-9f68-6640b6abd161.pdf",
            "news_date": "2023-02-15 14:38:09",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 14, 2023, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2022.<BR> The same were also reviewed by the Audit Committee in its meeting held on February 13, 2023. A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A. <BR> The Board Meeting commenced at 10:30 A.M. and concluded at 1:15 P.M.<BR> We request you to kindly bring the above information to the notice of your members.<BR> <BR>",
            "news_id": "9bc70dab-068f-474e-ab8f-e418cfe2c0e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cd6d72b-1e2a-482d-af2a-7f39e74704ae.pdf",
            "news_date": "2023-02-14 13:43:08",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. SEBI/HO/CFO/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed disclosure of related party transactions for half year ended September 30, 2022. This is for your kind information and record please.",
            "news_id": "3d7589ac-67dd-4950-800a-6d87b260bbe8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1a4d60e-c3e8-4ca3-a683-f252b155dc11.pdf",
            "news_date": "2022-11-29 14:59:09",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "We would like to inform you that Board of Directors of the Company has, at its meeting held today, i.e. 14.11.2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended 30.09.2022. The same were also reviewed by the Audit Committee in its meeting held earlier on 14.11.2022. A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A. <BR> <BR> We wish to further inform you that the Board of Directors has also decided the elevation of Dr. Rajesh Jain, Managing Director to the position of Chairman & Managing Director of the Company.<BR> <BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:40 P.M. <BR> <BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "e1ea7524-d1b5-455f-825e-ab6b131a4fe9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83b5bee2-094a-485d-8d8d-2caa311d5e51.pdf",
            "news_date": "2022-11-14 16:54:18",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2022",
            "news_body": "The Board of Directors of the Company has, at its meeting held today, i.e. August 09, 2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on August 09, 2022.<BR> <BR> A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A.<BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M.",
            "news_id": "f648e9d0-30e8-42b9-a796-0a0d55fc584b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eae1450a-4de7-4de4-b19d-e3fb49e4c99c.pdf",
            "news_date": "2022-08-09 15:30:38",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for  I.  Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2022<BR> Ii. Date, Time And Venue Of The 38Th AGM <BR>  Iii. Dates Of Book Closure",
            "news_body": "The Board of Directors of the Company has, at its meeting held on 09.08.2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on 09.08.2022.<BR> <BR> We wish to further inform you that the Board of Directors has also decided that:<BR> <BR> i) the 38th AGM of the Company will be held on Wednesday, 28.09.2022 at 11:30 A.M. through VC / Other Audio-Visual Means; and <BR> ii) the Register of Members and Share Transfer Books will remain closed from Wednesday, 21.09.2022 to Wednesday, 28.09.2022 (both days inclusive) for the purpose of AGM. <BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M.<BR>",
            "news_id": "07af3986-9634-4b61-8995-9d5d9317774a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7a61069-a9f3-41f2-b5c5-4e72c36a9ccf.pdf",
            "news_date": "2022-08-09 15:26:05",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2022",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. May 18, 2022, inter-alia, considered and approved the following:-<BR> a. Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on May 18, 2022. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. <BR> b. Seeking shareholders' approval through Postal Ballot for :<BR>   Appointment of Mr. Narotam Kumar Juneja (DIN: 01204817) as a Non-Executive Non-Independent Director; <BR>   Adoption of new set of Articles of Association of Company; and<BR>   Granting of loans, guarantees etc. and investment by way of acquisition of securities of any other bodies corporate & mutual funds etc. <BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 2:40 P.M.<BR>",
            "news_id": "201abafd-25f3-4696-aa82-083926802013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bea835e-99a6-4cba-8250-5f387fcf89d0.pdf",
            "news_date": "2022-05-18 15:01:11",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. May 18, 2022, inter-alia, considered and approved the following:-<BR> <BR> a. Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on May 18, 2022. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. <BR> b. Seeking shareholders' approval through Postal Ballot for :<BR>   Appointment of Mr. Narotam Kumar Juneja (DIN: 01204817) as a Non-Executive Non-Independent Director; <BR>   Adoption of new set of Articles of Association of Company; and<BR>   Granting of loans, guarantees etc. and investment by way of acquisition of securities of any other bodies corporate & mutual funds etc. <BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 2:40 P.M.<BR>",
            "news_id": "9fce5823-d847-4259-adb6-af1b1dda922a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b21bf3ba-e7d9-48d1-b649-0529b952d6c0.pdf",
            "news_date": "2022-05-18 14:53:29",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 14, 2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2021. <BR> <BR> Pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2021 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. <BR> <BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 04:00 P.M. <BR> <BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "4f193c6a-0b51-482d-80a9-66d2dae8f489",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89d659d5-6178-4e24-bb2e-e182f40dde83.pdf",
            "news_date": "2022-02-14 16:16:03",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "In continuation to our letter dated November 02, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. November 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended September 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on November 12, 2021.<BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 05:15 P.M. <BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "d4c2aa1a-a160-4062-926f-c7b19a56e045",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d0ede7d-0a0a-4ccd-a32e-0b060dd5f053.pdf",
            "news_date": "2021-11-12 17:40:23",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation to our letter dated July 28, 2021 and in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the revised Investor Presentation uploaded on the website of the Company at the link: https://www.panaceabiotec.com/comorate-presentation.<BR> The Company will now use this presentation for meetings with analysts / institutional investors.<BR> <BR> This is for your kind information and record please.",
            "news_id": "b5a82d7d-bd0d-4a39-860f-3c3ec9f902ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cee182a-92e6-42da-8a95-a26a9fd929bf.pdf",
            "news_date": "2021-08-02 11:08:32",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation uploaded on the website of the Company at the link: https://www.panaceabiotec.com/corporate-presentation.<BR> <BR> The Company will use this presentation for meetings with analysts / institutional investors.<BR> <BR> This is for your kind information and record please.",
            "news_id": "70e7c182-a35c-4104-bb9b-951136ff2181",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec4d923a-0b87-44b8-b2af-7f0341872c97.pdf",
            "news_date": "2021-07-28 14:00:34",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2021",
            "news_body": "In continuation to our letter dated July 15, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. July 23, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021.<BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M.<BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "7c893f2d-86a1-4866-bb92-e0a096e78dde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=282fd850-59d7-47f9-ab4e-7630dfd096db.pdf",
            "news_date": "2021-07-23 16:17:02",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held 23.07.2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021. <BR> We wish to further inform you that the Board of Directors has also decided that:<BR> i) the 37th Annual General Meeting of the Company will be held on Saturday, September 25, 2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means; and <BR> ii) the Register of Members and Share Transfer Books will remain closed from Saturday, September 18, 2021 to Saturday, September 25, 2021 (both days inclusive) for the purpose of Annual General Meeting. <BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M<BR>",
            "news_id": "e5f108b1-c364-47b7-bf83-ebb0517830cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bc6945c-3115-4d9b-a5e0-3856010a09fe.pdf",
            "news_date": "2021-07-23 16:11:22",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "In continuation to our letter dated May 24, 2021 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. June 02, 2021 approved the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021 in terms of Regulation 33 of SEBI LODR Regulations. <BR> <BR> The same were also reviewed by the Audit Committee in its meeting held earlier on June 02, 2021. A copy of the aforesaid Audited Financial Results (Standalone and Consolidated) along with Auditors' Report is enclosed herewith.",
            "news_id": "75ba61f9-a334-467a-85c4-fba153a7d2ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f93ec383-3a82-4cad-be7e-e8c28ea81ba9.pdf",
            "news_date": "2021-06-02 19:32:49",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today 02.06.2021, inter-alia, considered and approved the following:-<BR> <BR> 1. Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on 02.06.2021. <BR> 2. Raising of funds by the Company through one or more permissible mechanisms as may be deemed appropriate by the Board, for an amount upto and not exceeding INR 12,000 million or its equivalent in any other currency(ies), in one or more tranches, subject to the approval of the Shareholders of the Company and any other regulatory or statutory approvals, as may be required; and<BR> 3. Convening of EGM of the Company on 25.06.2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means.<BR> The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 07:15 P.M.  <BR>",
            "news_id": "69eab47f-509f-44f8-8e22-c1c4f54415b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee7078ac-fa67-4bb6-abf6-cdf3098d24dc.pdf",
            "news_date": "2021-06-02 19:22:59",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI LODR Regulations, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2020. The same were also reviewed by the Audit Committee in its meeting held earlier on February 12, 2021. <BR> <BR> Further, pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2020 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. <BR> <BR> The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 05:10 P.M<BR>",
            "news_id": "67a5952f-b2f0-4632-a001-ea270d2ac9b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5b6133d-e531-4944-9461-36f9c0ea29ab.pdf",
            "news_date": "2021-02-12 17:31:08",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2020",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI LODR Regulations, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2020. The same were also reviewed by the Audit Committee in its meeting held earlier on February 12, 2021. <BR> <BR> Further, pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2020 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. <BR> <BR> The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 05:10 P.M<BR>",
            "news_id": "388e63ca-1b31-472c-88b3-f6722ba291b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=379ab44a-f680-44a3-bf80-8ed5267c0155.pdf",
            "news_date": "2021-02-12 17:27:55",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}